Unknown

Dataset Information

0

Characterization of Reference Materials for Genetic Testing of CYP2D6 Alleles: A GeT-RM Collaborative Project.


ABSTRACT: Pharmacogenetic testing increasingly is available from clinical and research laboratories. However, only a limited number of quality control and other reference materials currently are available for the complex rearrangements and rare variants that occur in the CYP2D6 gene. To address this need, the Division of Laboratory Systems, CDC-based Genetic Testing Reference Material Coordination Program, in collaboration with members of the pharmacogenetic testing and research communities and the Coriell Cell Repositories (Camden, NJ), has characterized 179 DNA samples derived from Coriell cell lines. Testing included the recharacterization of 137 genomic DNAs that were genotyped in previous Genetic Testing Reference Material Coordination Program studies and 42 additional samples that had not been characterized previously. DNA samples were distributed to volunteer testing laboratories for genotyping using a variety of commercially available and laboratory-developed tests. These publicly available samples will support the quality-assurance and quality-control programs of clinical laboratories performing CYP2D6 testing.

SUBMITTER: Gaedigk A 

PROVIDER: S-EPMC6854474 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Characterization of Reference Materials for Genetic Testing of CYP2D6 Alleles: A GeT-RM Collaborative Project.

Gaedigk Andrea A   Turner Amy A   Everts Robin E RE   Scott Stuart A SA   Aggarwal Praful P   Broeckel Ulrich U   McMillin Gwendolyn A GA   Melis Roberta R   Boone Erin C EC   Pratt Victoria M VM   Kalman Lisa V LV  

The Journal of molecular diagnostics : JMD 20190809 6


Pharmacogenetic testing increasingly is available from clinical and research laboratories. However, only a limited number of quality control and other reference materials currently are available for the complex rearrangements and rare variants that occur in the CYP2D6 gene. To address this need, the Division of Laboratory Systems, CDC-based Genetic Testing Reference Material Coordination Program, in collaboration with members of the pharmacogenetic testing and research communities and the Coriel  ...[more]

Similar Datasets

| S-EPMC11284628 | biostudies-literature
| S-EPMC2962854 | biostudies-literature
| S-EPMC4695224 | biostudies-literature
| S-EPMC6939753 | biostudies-literature
| S-EPMC2876147 | biostudies-literature
| S-EPMC2765754 | biostudies-literature
| S-EPMC4609882 | biostudies-literature
| S-EPMC2671335 | biostudies-literature
| S-EPMC10807056 | biostudies-literature
| S-EPMC9605556 | biostudies-literature